🚀 VC round data is live in beta, check it out!
European Medical Solutions Valuation Multiples
Discover revenue and EBITDA valuation multiples for European Medical Solutions and similar public comparables like Finemedix, Cambridge Cognition, Harvard Bioscience, Nortech Systems and more.
European Medical Solutions Overview
About European Medical Solutions
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
Founded
1997
HQ
Employees
20
Website
Sectors
Financials (FY)
EV
$45M
European Medical Solutions Financials
European Medical Solutions reported last fiscal year revenue of $52M and EBITDA of $4M.
In the same fiscal year, European Medical Solutions generated $17M in gross profit, $4M in EBITDA, and $634K in net income.
European Medical Solutions P&L
In the most recent fiscal year, European Medical Solutions reported revenue of $52M and EBITDA of $4M.
European Medical Solutions expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $52M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $17M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 33% | XXX | XXX | XXX |
| EBITDA | — | XXX | $4M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 3% | XXX | XXX | XXX |
| Net Profit | — | XXX | $634K | XXX | XXX | XXX |
| Net Margin | — | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $14M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
European Medical Solutions Stock Performance
European Medical Solutions has current market cap of $27M, and enterprise value of $45M.
Market Cap Evolution
European Medical Solutions' stock price is $6.31.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $45M | $27M | (0.2%) | XXX | XXX | XXX | $0.15 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEuropean Medical Solutions Valuation Multiples
European Medical Solutions trades at 0.9x EV/Revenue multiple, and 10.3x EV/EBITDA.
European Medical Solutions Financial Valuation Multiples
As of March 7, 2026, European Medical Solutions has market cap of $27M and EV of $45M.
Equity research analysts estimate European Medical Solutions' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
European Medical Solutions has a P/E ratio of 42.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $27M | XXX | $27M | XXX | XXX | XXX |
| EV (current) | $45M | XXX | $45M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 10.3x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 27.4x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.6x | XXX | XXX | XXX |
| P/E | — | XXX | 42.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (38.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified European Medical Solutions Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
European Medical Solutions Margins & Growth Rates
European Medical Solutions' revenue in the last fiscal year grew by 11%.
European Medical Solutions Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 86% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
European Medical Solutions Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Finemedix | XXX | XXX | XXX | XXX | XXX | XXX |
| Cambridge Cognition | XXX | XXX | XXX | XXX | XXX | XXX |
| Harvard Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Nortech Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Inspira Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
European Medical Solutions M&A Activity
European Medical Solutions acquired XXX companies to date.
Last acquisition by European Medical Solutions was on XXXXXXXX, XXXXX. European Medical Solutions acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by European Medical Solutions
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEuropean Medical Solutions Investment Activity
European Medical Solutions invested in XXX companies to date.
European Medical Solutions made its latest investment on XXXXXXXX, XXXXX. European Medical Solutions invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by European Medical Solutions
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout European Medical Solutions
| When was European Medical Solutions founded? | European Medical Solutions was founded in 1997. |
| Where is European Medical Solutions headquartered? | European Medical Solutions is headquartered in Belgium. |
| How many employees does European Medical Solutions have? | As of today, European Medical Solutions has over 20 employees. |
| Is European Medical Solutions publicly listed? | Yes, European Medical Solutions is a public company listed on Euronext Brussels. |
| What is the stock symbol of European Medical Solutions? | European Medical Solutions trades under ALEMS ticker. |
| When did European Medical Solutions go public? | European Medical Solutions went public in 2016. |
| Who are competitors of European Medical Solutions? | European Medical Solutions main competitors are Finemedix, Cambridge Cognition, Harvard Bioscience, Nortech Systems. |
| What is the current market cap of European Medical Solutions? | European Medical Solutions' current market cap is $27M. |
| What is the current revenue of European Medical Solutions? | European Medical Solutions' last fiscal year revenue is $52M. |
| What is the current EV/Revenue multiple of European Medical Solutions? | Current revenue multiple of European Medical Solutions is 0.9x. |
| Is European Medical Solutions profitable? | No, European Medical Solutions is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.